Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-24 Purchase | 2024-09-26 09:33 am | Reneo Pharmaceuticals Inc. | RPHM | Leonard Braden Michael 10% Owner | 98,346 | $1.4717 | $144,738 | 4,478,164 (Indirect Direct) | View |
| 2024-09-17 Purchase | 2024-09-19 11:02 am | Reneo Pharmaceuticals Inc. | RPHM | Leonard Braden Michael 10% Owner | 56,106 | $1.3588 | $76,237 | 4,379,818 (Indirect Direct) | View |
| 2024-09-12 Purchase | 2024-09-16 4:15 pm | Reneo Pharmaceuticals Inc. | RPHM | Leonard Braden Michael 10% Owner | 358,923 | $1.3494 | $484,344 | 4,323,712 (Indirect Direct) | View |
| 2024-08-13 Purchase | 2024-08-14 8:48 pm | Reneo Pharmaceuticals Inc. | RPHM | Leonard Braden Michael 10% Owner | 271,826 | $1.4002 | $380,598 | 3,964,789 (Indirect Direct) | View |
| 2024-05-14 Purchase | 2024-05-16 08:58 am | Reneo Pharmaceuticals Inc. | RPHM | Leonard Braden Michael 10% Owner | 414,281 | $1.5438 | $639,578 | 3,692,963 (Indirect Direct) | View |
| 2023-08-28 Sale | 2023-08-29 5:04 pm | Reneo Pharmaceuticals Inc. | RPHM | Hall Ashley Chief Development Officer | 15,625 | $6.2757 | $98,058 | 148,975 (Direct) | View |
| 2023-06-23 Sale | 2023-06-23 7:15 pm | Reneo Pharmaceuticals Inc. | RPHM | Novo Holdings A/S 10% Owner | 100,000 | $7.0974 | $709,740 | 3,330,337 (Direct) | View |
| 2023-05-08 Purchase | 2023-05-10 5:47 pm | Reneo Pharmaceuticals Inc. | RPHM | O'Donnell Niall Director | 125,000 | $8 | $1,000,000 | 2,188,713 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-10-15 4:08 pm | N/A N/A | OnKure Therapeutics Inc. | OKUR | Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Cormorant Private Healthcare Fund IV LP Cormorant Private Healthcare Fund V LP Chen Bihua 10% Owner | 0 | $0 | 1,837,739 (Indirect) | View |
Ownership | 2024-10-09 4:15 pm | N/A N/A | OnKure Therapeutics Inc. | OKUR | ACORN BIOVENTURES L.P. ACORN CAPITAL ADVISORS GP LLC Hove Anders D 10% Owner | 0 | $0 | 1,439,674 (Direct) | View |
| 2024-10-07 Other | 2024-10-09 11:25 am | N/A N/A | OnKure Therapeutics Inc. | OKUR | Leonard Braden Michael Former 10% owner of RPHM | 447,815 | $0 | 895,630 (Indirect) | View |
| 2024-10-04 Option Award | 2024-10-08 7:29 pm | N/A 2032-01-10 | OnKure Therapeutics Inc. | OKUR | Saccomano Nicholas A President and CEO | 575,979 | $0 | 575,979 (Direct) | View |
| 2024-10-04 Option Award | 2024-10-08 7:28 pm | N/A 2034-10-03 | OnKure Therapeutics Inc. | OKUR | Phillips Andrew John Director | 15,300 | $0 | 15,300 (Direct) | View |
| 2024-10-04 Option Award | 2024-10-08 7:27 pm | N/A 2034-10-03 | OnKure Therapeutics Inc. | OKUR | Mathers Edward T Director | 15,300 | $0 | 15,300 (Direct) | View |
| 2024-10-04 Option Award | 2024-10-08 7:27 pm | N/A 2034-10-03 | OnKure Therapeutics Inc. | OKUR | Manke Isaac Director | 15,300 | $0 | 15,300 (Direct) | View |
| 2024-10-04 Option Award | 2024-10-08 7:26 pm | N/A 2032-01-10 | OnKure Therapeutics Inc. | OKUR | Leverone Jason A. Chief Financial Officer | 158,045 | $0 | 158,045 (Direct) | View |
| 2024-10-04 Option Award | 2024-10-08 7:25 pm | N/A 2034-10-03 | OnKure Therapeutics Inc. | OKUR | Jansen Valerie Malyvanh Director | 15,300 | $0 | 15,300 (Direct) | View |
| 2024-10-04 Option Award | 2024-10-08 7:24 pm | N/A 2034-10-03 | OnKure Therapeutics Inc. | OKUR | Hartley Dylan Chief Scientific Officer | 137,603 | $0 | 137,603 (Direct) | View |
| 2024-10-04 Option Award | 2024-10-08 7:23 pm | N/A 2034-10-03 | OnKure Therapeutics Inc. | OKUR | GREY MICHAEL G Director | 15,300 | $0 | 15,300 (Direct) | View |
| 2024-10-04 Option Award | 2024-10-08 7:21 pm | N/A 2031-07-06 | OnKure Therapeutics Inc. | OKUR | Carruthers R Michael Director | 23,323 | $0 | 23,323 (Direct) | View |
| 2024-10-04 Option Award | 2024-10-08 7:20 pm | N/A 2034-02-05 | OnKure Therapeutics Inc. | OKUR | Agresta Samuel Chief Medical Officer | 149,984 | $0 | 149,984 (Direct) | View |
Ownership | 2024-05-16 08:56 am | N/A N/A | Reneo Pharmaceuticals Inc. | RPHM | Leonard Braden Michael 10% Owner | 0 | $0 | 3,692,963 (Indirect) | View |
| 2023-08-28 Exercise | 2023-08-29 5:04 pm | N/A 2032-12-08 | Reneo Pharmaceuticals Inc. | RPHM | Hall Ashley Chief Development Officer | 15,625 | $0 | 148,975 (Direct) | View |
| 2023-08-28 Exercise | 2023-08-29 5:04 pm | N/A N/A | Reneo Pharmaceuticals Inc. | RPHM | Hall Ashley Chief Development Officer | 15,625 | $1.8 | 148,975 (Direct) | View |
| 2023-07-26 Gift | 2023-07-27 5:16 pm | N/A N/A | Reneo Pharmaceuticals Inc. | RPHM | GREY MICHAEL G Executive Chairman | 50,000 | $0 | 628,846 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 8:09 pm | N/A 2033-06-05 | Reneo Pharmaceuticals Inc. | RPHM | Mathers Edward T Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 6:17 pm | N/A 2033-06-05 | Reneo Pharmaceuticals Inc. | RPHM | Blunt Roshawn A. Director | 14,815 | $0 | 14,815 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 6:16 pm | N/A 2033-06-05 | Reneo Pharmaceuticals Inc. | RPHM | GREY MICHAEL G Executive Chairman | 17,500 | $0 | 17,500 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 6:15 pm | N/A 2033-06-05 | Reneo Pharmaceuticals Inc. | RPHM | Hoelscher Paul W. Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 6:14 pm | N/A 2033-06-05 | Reneo Pharmaceuticals Inc. | RPHM | Muralidhar Bali Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 6:13 pm | N/A 2033-06-05 | Reneo Pharmaceuticals Inc. | RPHM | O'Donnell Niall Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 6:06 pm | N/A 2033-06-05 | Reneo Pharmaceuticals Inc. | RPHM | Seltzer Stacey Denenberg Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 6:02 pm | N/A 2033-06-05 | Reneo Pharmaceuticals Inc. | RPHM | Dube Eric M Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2022-12-09 Option Award | 2022-12-13 6:13 pm | N/A 2032-12-08 | Reneo Pharmaceuticals Inc. | RPHM | Lam Jennifer VP of Finance & Administration | 90,000 | $0 | 110,600 (Direct) | View |